Celldex Therapeutics, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes therapeutic antibodies, antibody drug conjugates, vaccines, and immune system modulators. The company's drug candidates include Glembatumumab vedotin, Varlilumab, CDX-1401, CDX-301, and Rintega. Celldex Therapeutics was founded by Anthony S. Marucci and Tibor Keler in 1983 and is headquartered in Hampton, NJ.

Recent Equity Price Chart

Loading...

Bullish Trades

Call trades that are bought on or above the market's asking price OR put trades that are sold on or less than the market's bid price - expecting a move to the updside.



Type Expiration DTE Bid Purchase Price Ask Spread Strike Total Traded Size Volume Trade Condition Timestamp Notes
Call Login To View Login To View Login To View Login To View Login To View Login To View Login To View $120,000.00 Login To View Login To View 22 days ago Login To View